NCT01907906View on ClinicalTrials.gov

Inactivation of Whole Blood With Mirasol

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Focus of Study: Radiolabel Recovery and Survival of RBCs
Interventions
DEVICE

Mirasol System for Whole Blood

LR-pRBC units derived from WB will be treated with the Mirasol System. Treatment with the Mirasol System requires riboflavin to be mixed into the whole blood unit, which is then exposed to ultra violet (UV) light for a period of time; approximately an hour.

Trial Locations (2)

45267

Hoxworth Blood Center, Cincinnati

98104

Puget Sound Blood Center, Seattle

All Listed Sponsors
collaborator

U.S. Army Medical Research and Development Command

FED

lead

Terumo BCTbio

INDUSTRY

NCT01907906 - Inactivation of Whole Blood With Mirasol | Biotech Hunter | Biotech Hunter